Search - tctmd.com

Displaying 721 - 740 of 1012

Sort: Relevancy | Date

Presentation TCT 2015

Debate: Fate of the Multidisciplinary Heart Valve Team as TAVR Becomes a TF-First Minimalist Procedure That Would Be a Mistake!

Presenter: Eberhard Grube, Michael J. Mack, A. Pieter Kappetein

October 11, 2015

Presentation TCT 2015

Everything You Wanted to Know About Endovascular Radiation Hazards but Were Afraid to Ask

Presenter: Gary M. Ansel, Michael R. Jaff, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

Pioneers Corner: Reflections on the Impact of TAVR on Aortic Valve Therapy (Now and in the Future) The Noninvasive Cardiologists Perspective

Presenter: Eberhard Grube, Michael J. Mack, Robert O. Bonow

October 11, 2015

Presentation TCT 2015

Pioneers Corner: Reflections on the Impact of TAVR on Aortic Valve Therapy (Now and in the Future) The Cardiac Surgeons Perspective

Presenter: Eberhard Grube, Michael J. Mack

October 11, 2015

Presentation TCT 2015

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Presenter: Gary M. Ansel, Michael R. Jaff, Ori Ben-Yehuda

October 11, 2015

Presentation TCT 2015

Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment

Presenter: Ajay J. Kirtane, Felix Mahfoud, Michael A. Weber

October 11, 2015

Presentation TCT 2015

Is Peripheral Vascular Intervention Cost-effective? If So, From Whose Perspective?

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation TCT 2015

Acute Coronary Syndrome: STEMI

Presenter: Peter Barlis, Greg L. Kaluza, Michael C. Kim

October 11, 2015

Presentation TCT 2015

How to Handle Outliers in the Lab

Presenter: Michael A. Kutcher, Sunil V. Rao

October 11, 2015

Presentation TCT 2015

Shining Light on the Sunshine Act

Presenter: Michael A. Kutcher, Sunil V. Rao, Peter L Duffy

October 11, 2015

Presentation Aortovascular 2015

The Medical Treatment of the Patient with PAD in the 21st Century

Presenter: Michael R. Jaff

September 18, 2015

Presentation ESC 2015

CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients?

Presenter: Michael Ovize

August 30, 2015

Presentation

2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR

Presenter: Michael J. Reardon

July 06, 2015

Presentation TVT 2015

A Surgeons View: Will I Be in the Room in the Future?

Presenter: Susheel K. Kodali, David A. Wood, Michael J. Reardon

June 06, 2015

Presentation TVT 2015

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Jonathon A. Leipsic, Jeffrey J. Popma, Michael J. Reardon

June 05, 2015

Presentation TVT 2015

Direct Aortic TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, Michael J. Reardon

June 04, 2015

Presentation TVT 2015

Implications From the Recent CTSN Trials of Mitral Valve Repair and Replacement for the Surgical Standard and Mitral Device Development

Presenter: Gregg W. Stone, Alec S. Vahanian, Wesley R. Pedersen, Michael Argenziano

June 04, 2015

Presentation Fellows 2015

Update on Mitral Valve Disease and Transcatheter Therapies

Presenter: Mark Reisman, Nirat Beohar, Michael J. Rinaldi

May 17, 2015

Presentation Fellows 2015

Physiologic Lesion Assessment in the Cath Lab

Presenter: Gary S. Mintz, Ajay J. Kirtane, Michael J. Lim

May 16, 2015

Presentation ECHO 2015

The wide spectrum of cardiomyopathy: rapid fire case review

Presenter: Michael H. Picard

April 27, 2015

Advertisement

Debate: Fate of the Multidisciplinary Heart Valve Team as TAVR Becomes a TF-First Minimalist Procedure That Would Be a Mistake!

Everything You Wanted to Know About Endovascular Radiation Hazards but Were Afraid to Ask

Pioneers Corner: Reflections on the Impact of TAVR on Aortic Valve Therapy (Now and in the Future) The Noninvasive Cardiologists Perspective

Pioneers Corner: Reflections on the Impact of TAVR on Aortic Valve Therapy (Now and in the Future) The Cardiac Surgeons Perspective

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment

Is Peripheral Vascular Intervention Cost-effective? If So, From Whose Perspective?

Acute Coronary Syndrome: STEMI

How to Handle Outliers in the Lab

Shining Light on the Sunshine Act

The Medical Treatment of the Patient with PAD in the 21st Century

CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients?

2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR

A Surgeons View: Will I Be in the Room in the Future?

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Direct Aortic TAVR: Optimal Technique and Complication Management

Implications From the Recent CTSN Trials of Mitral Valve Repair and Replacement for the Surgical Standard and Mitral Device Development

Update on Mitral Valve Disease and Transcatheter Therapies

Physiologic Lesion Assessment in the Cath Lab

The wide spectrum of cardiomyopathy: rapid fire case review

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content